I-Mab (Hangzhou)

Hangzhou, China · Founded 2019 · Privately Held (backing)

Manufacturer of macromolecular antibody drugs focused on integrated biopharmaceutical research and production. I-Mab (Hangzhou) is based in Hangzhou, China and was founded in 2019. It has raised $154 million.

Last price · $/share
—
Implied valuation
—
Total raised
$154.3M
Last round
—

Who backs I-Mab (Hangzhou)?

23 investors
InvestorType
HSG (Hong Kong)Other
CICC CapitalPE / buyout
Oriental Fortune CapitalVenture capital
Tailong VCOther
HaiBang VenturesOther
Heda VenturesOther
Yijing CapitalVenture capital
Hangzhou Industrial Investment GroupOther
Zhuzhou SAH Innovation & Entrepreneur InvestmentOther
Qingdao Conson Financial HoldingsOther
+ 13 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

I-Mab (Hangzhou) investors

23 investors are on record for I-Mab (Hangzhou), including HSG (Hong Kong), CICC Capital, Oriental Fortune Capital and Tailong VC.

Free account
More of I-Mab (Hangzhou) with a free account
  • ·The complete investor list: 23 names
  • ·Watch I-Mab (Hangzhou): the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 23 firms already write checks for companies like I-Mab (Hangzhou). Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View